RecruitingNot applicableNCT05420064
An Intervention to Increase Genetic Testing in Families Who May Share a Gene Mutation Related to Cancer Risk and An Intervention to Help Patients and Their Primary Care Providers Stay Up-to-date About Uncertain Genetic Test Results
Studying Adult-onset leukoencephalopathy with axonal spheroids and pigmented glia
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Principal Investigator
- Kenneth Offit, MD, MPHMemorial Sloan Kettering Cancer Center
- Intervention
- Intervention Arm At-risk Relative/ARR Contacts(behavioral)
- Enrollment
- 1000 enrolled
- Eligibility
- 25 years · All sexes
- Timeline
- 2022 – 2026
Study locations (8)
- Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities), Basking Ridge, New Jersey, United States
- Memorial Sloan Kettering Monmouth (Limited Protocol Activities), Middletown, New Jersey, United States
- Memorial Sloan Kettering Bergen (Limited Protocol Activity), Montvale, New Jersey, United States
- Memorial Sloan Kettering Suffolk - Commack (Limited Protocol Activities), Commack, New York, United States
- Memorial Sloan Kettering Westchester (Limited Protocol Activities), Harrison, New York, United States
- Memorial Sloan Kettering Cancer Center, New York, New York, United States
- MSK at Ralph Lauren (Limited Protocol Activities), New York, New York, United States
- Memorial Sloan Kettering Nassau (Limited Protocol Activity), Uniondale, New York, United States
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT05420064 on ClinicalTrials.govOther trials for Adult-onset leukoencephalopathy with axonal spheroids and pigmented glia
Additional recruiting or active studies for the same condition.
- RECRUITINGNCT06190834Relationship Between High-Density Lipoprotein Subtypes and Coronary Heart Disease Prognosis.Beijing Tsinghua Chang Gung Hospital
- RECRUITINGNCT05103969Cohort of Tumors With POLE/D1 MutationFederation Francophone de Cancerologie Digestive
- ENROLLING BY INVITATIONNCT04503213A Study to Assess CSF1R-related Leukoencephalopathy After Stem Cell TransplantationMayo Clinic
- RECRUITINGPHASE2NCT03810339Toripalimab as Monotherapy in Participants With POLE or POLD-1 Mutated and Non-MSI-H Advanced Solid TumorsSun Yat-sen University
- ACTIVE NOT RECRUITINGPHASE2NCT03428802Pembrolizumab in Treating Participants With Metastatic, Recurrent or Locally Advanced Cancer and Genomic InstabilityRutgers, The State University of New Jersey
See all trials for Adult-onset leukoencephalopathy with axonal spheroids and pigmented glia →